Table 2.
Brighton criteria and its association with other clinical findings
|
Brighton
score |
Percentage |
Gender (%)
|
Prognosis (%)
|
NCS findings (%)
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Good | Poor | AIDP | AMAN | AMSAN | Normal | Other | ||
| 1 | 41.4 | 50.1 | 49.1 | 87.2 | 12.8 | 79.2 | 3.8 | 9.4 | 5.7 | 1.9 |
| 2 | 51.6 | 65.5 | 34.8 | 74.5 | 25.5 | 66.7 | 7.6 | 6.1 | 6.1 | 13.6 |
| 4 | 7.0 | 88.9 | 11.1 | 100 | - | 44.4 | - | 11.1 | 22.2 | 22.2 |
NCS: Nerve conduction study; AIDP: Acute inflammatory demyelinating polyneuropathy; AMAN: Acute motor axonal neuropathy; AMSAN: Acute motor sensory axonal neuropathy